logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
N

Neha Korde

Memorial Sloan Kettering Cancer Center
H指数:40
被引数:5,875

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Stem cell autograft minimal residual disease negativity and survival outcomes for multiple myeloma autotransplant

自体干细胞移植后微小残留病阴性及多发性骨髓瘤自体移植的生存结局

Blood Cancer Journal
IF11.6
2026-09-220
OAAI
Noriko Nishimura; Samantha Brown; Sarah Samorodnitsky; Sean M. Devlin; Mohammad Alhomoud; Parastoo Dahi; Charlotte Hughes; Eric Jergens; Heather J. Landau; Oscar B. Lahoud; Michael Scordo; Gunjan L. Shah; Ross Firestone; Hamza Hashmi; Hani Hassoun; Malin Hultcrantz; Neha Korde; Alexander M. Lesokhin; Kylee Maclachlan; Sham Mailankody; Francesco Maura; Maximilian Merz; Sridevi Rajeeve; Urvi A. Shah; Carlyn R. Tan; Gaurav K. Gupta; Elena Maryamchik; Evangelos Ntrivalas; Qi Gao; Mikhail Roshal; Saad Z. Usmani; Sergio A. Giralt; David J. Chung
Impact of granulocyte colony-stimulating factors on cytokine release syndrome during bispecific antibody initiation in relapsed/refractory multiple myeloma

粒细胞集落刺激因子对双特异性抗体启动期间细胞因子释放综合征的影响：在复发/难治性多发性骨髓瘤中的作用

Blood Cancer Journal
IF11.6
2026-08-070
OAAI
Alice X. Wang; Tala Shekarkhand; David Nemirovsky; Andriy Derkach; Carlyn R. Tan; Issam S. Hamadeh; Ross S. Firestone; Eric Jurgens; Kevin Miller; Dhwani Patel; Neha Korde; Alexander M. Lesokhin; Sham Mailankody; Hani Hassoun; Hamza Hashmi; Sridevi Rajeeve; Urvi A. Shah; Kylee Maclachlan; Gunjan L. Shah; Michael Scordo; Heather J. Landau; Sergio A. Giralt; Saad Z. Usmani; Malin Hultcrantz
Robust CD4+ CAR T cell expansion is associated with non-ICANS neurotoxicities after ciltacabtagene autoleucel in patients with multiple myeloma

在多发性骨髓瘤患者中，强效CD4+ CAR T细胞扩增与非ICANS神经毒性的发生相关（cilta-cel治疗）

Science Translational Medicine
IF14.6
2026-07-290
PRE
Eric M. Jurgens; Sneha Mitra; Kevin Herrera; David Nemirovsky; Brenden Bready; Andriy Derkach; Kinga Hosszu; Devin McAvoy; Ross S. Firestone; Sridevi Rajeeve; Alexander M. Lesokhin; Neha Korde; Carlyn R. Tan; Hamza Hashmi; Hani Hassoun; Kylee Maclachlan; Urvi A. Shah; Malin Hultcrantz; Maximilian Merz; Francesco Maura; Sergio A. Giralt; Gunjan L. Shah; Heather J. Landau; Michael Scordo; Ivan S. Kotchetkov; Bianca D. Santomasso; Jae Park; Christina S. Leslie; Saad Z. Usmani; Karlo Perica; Sham Mailankody
Whole-genome sequencing of cell-free DNA for assessment of minimal residual disease in high-risk smoldering multiple myeloma

无细胞DNA全基因组测序在评估高风险冒烟型多发性骨髓瘤微小残留病中的应用

HemaSphere
IF14.6
2026-04-160
OAAI
Chrissy Baker; Elizabeth Hill; Dickran Kazandjian; Marios Papadimitriou; Michael Durante; Abhishek Pandey; Bachisio Ziccheddu; Tomas Jelinek; David Coffey; Brian Walker; Ryan Young; Kylee Maclachlan; Neha Korde; Nickoli Parkinson; Zoe R. Goldstein; Alexi Runnels; William F. Hooper; Dan Landau; Nicolas Robine; Francesco Maura; Ola Landgren; Benjamin Diamond
Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma

功能性高风险疾病与多发性骨髓瘤晚期CAR T细胞疗法后的不良预后相关

Blood Cancer Journal
IF11.6
2026-04-120
OAAI
Hamza Hashmi; Tara Sebastian; Sridevi Rajeeve; Tasmin Farzana; Ross S. Firestone; Eric M. Jurgens; Kevin C. Miller; Francesco Maura; Alexander M. Lesokhin; Carlyn R. Tan; Gunjan L. Shah; Neha Korde; Heather J. Landau; Maximillian Merz; Michael Scordo; Hani Hassoun; Kylee H. Maclachlan; Urvi A. Shah; Malin L. Hultcrantz; Andriy Derkach; David Nemirovsky; Sergio Giralt; Sham Mailankody; Saad Z. Usmani
Cytomegalovirus reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma

双特异性抗体治疗复发/难治性多发性骨髓瘤期间巨细胞病毒再激活

Blood Cancer Journal
IF11.6
2025-11-010
OAAI
Eric Jurgens; Tala Shekarkhand; Colin Rueda; David Nemirovsky; Andriy Derkach; Ross S. Firestone; Kevin Miller; Bruno Almeida Costa; Sridevi Rajeeve; Alexander M. Lesokhin; Neha Korde; Carlyn R. Tan; Hamza Hashmi; Hani Hassoun; Kylee Maclachlan; Urvi A. Shah; Malin Hultcrantz; Issam Hamadeh; Sergio A. Giralt; Gunjan L. Shah; Heather J. Landau; Michael Scordo; Saad Z. Usmani; Sham Mailankody; Zainab Shahid
Correction: Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma

更正：达鲁珠单抗耐药性对复发难治性多发性骨髓瘤接受CAR T细胞治疗后临床结局的影响

Blood Cancer Journal
IF11.6
2025-10-130
OA
Tara Sebastian; Sridevi Rajeeve; Tasmin Farzana; Ross Firestone; Eric Jurgens; Kevin Miller; Bruno Almeida Costa; Alexander Lesokhin; Carlyn Rose Tan; Gunjan Shah; Neha Korde; Heather Landau; Michael Scordo; Hani Hassoun; Kylee Maclachlan; Urvi Shah; Malin Hultcrantz; Andriy Derkach; Derkach Nemirovsky; Sergio Giralt; Saad Usmani; Sham Mailankody; Hamza Hashmi
Temporal genomic dynamics shape clinical trajectory in multiple myeloma

时间基因组动力学塑造多发性骨髓瘤的临床轨迹

Nature Genetics
IF0
2025-08-200
OA
Francesco Maura; Marcella Kaddoura; Alexandra M. Poos; Linda B. Baughn; Bachisio Ziccheddu; Marc-Andrea Bärtsch; Anthony Cirrincione; Kylee Maclachlan; Monika Chojnacka; Benjamin Diamond; Marios Papadimitriou; Patrick Blaney; Lukas John; Philipp Reichert; Stefanie Huhn; Dylan Gagler; Yanming Zhang; Ahmet Dogan; Alexander M. Lesokhin; Faith Davies; Hartmut Goldschmidt; Roland Fenk; Katja C. Weisel; Elias K. Mai; Neha Korde; Gareth J. Morgan; S. Vincent Rajkumar; Shaji Kumar; Saad Usmani; Ola Landgren; Marc S. Raab; Niels Weinhold
Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma

daratumumab难治性对复发性难治性多发性骨髓瘤CAR T细胞治疗后临床结局的影响

Blood Cancer Journal
IF11.6
2025-08-140
OAAI
T. Sebastian; S. Rajeeve; T. Farzana; R. Firestone; E. Jurgens; K. Miller; B. Costa; A. Lesokhin; C. Tan; G. Shah; N. Korde; H. Landau; M. Scordo; H. Hassoun; K. Maclachlan; U. Shah; M. Hultcrantz; A. Derkach; D. Nemirovsky; S. Giralt; S. Z. Usmani; S. Mailankody; H. Hashmi
Outcomes in frail patients receiving BCMA-directed bispecific antibodies for relapsed/refractory multiple myeloma

老年体弱患者接受BCMA靶向双特异性抗体治疗复发/难治性多发性骨髓瘤的结局

Blood Advances
IF7.1
2025-05-060
OA
Benjamin Adegbite; Carlyn Rose Tan; Tala Shekarkhand; Ross S. Firestone; Eric M. Jurgens; Kevin Miller; Alexander M. Lesokhin; Gunjan L. Shah; Neha Korde; Sridevi Rajeeve; Heather J. Landau; Michael Scordo; Hani Hassoun; Kylee H. Maclachlan; Urvi A. Shah; Malin Hultcrantz; Issam S. Hamadeh; Andriy Derkach; David Nemirovsky; Sergio A. Giralt; Sham Mailankody; Saad Z. Usmani; Hamza Hashmi
Infectious Complications during Treatment with Commercial CAR T-Cell Therapy and Bispecific Antibodies for Relapsed/Refractory Multiple Myeloma

商业化CAR T细胞疗法和双特异性抗体治疗复发/难治性多发性骨髓瘤期间的感染并发症

BLOOD
IF23.1
2024-11-050
PRE
Jurgens, Eric M.; Shekarkhand, Tala; Farzana, Tasmin; Rueda, Colin; Nemirovsky, David; Derkach, Andriy; Firestone, Ross S.; Nishimura, Noriko; Miller, Kevin; Costa, Bruno Almeida; Nath, Karthik; Rajeeve, Sridevi; Lesokhin, Alexander M.; Korde, Neha; Tan, Carlyn Rose; Hashmi, Hamza; Hassoun, Hani; Maclachlan, Kylee H.; Shah, Urvi A.; Hultcrantz, Malin; Hamadeh, Issam S.; Giralt, Sergio A.; Chung, David J.; Landau, Heather J.; Scordo, Michael; Shah, Gunjan L.; Usmani, Saad Z.; Mailankody, Sham; Shahid, Zainab
Manufacture of Anti-BCMA CAR T Cell Is Feasible after Salvage Autologous or Allogeneic Hematopoietic Stem Cell Transplantation

自体或异基因造血干细胞移植后，生产抗BCMA CAR T细胞是可行的。

BLOOD
IF23.1
2024-11-050
PRE
Shah, Gunjan L.; Perica, Karlo; Nagel, Katherine; Payson, Erica; Hosszu, Kinga K.; Chung, David J.; Landau, HeatherJ.; Scordo, Michael; Hultcrantz, Malin; Korde, Neha; Maclachlan, Kylee H.; Shah, Urvi A.; Tan, Carlyn Rose; Hashmi, Hamza; Lesokhin, Alexander M.; Rajeeve, Sridevi; Usmani, Saad Z.; Mailankody, Sham; Giralt, Sergio A.
Defining the Rates of Cytokine Release Syndrome Associated with Talquetamab Step-up Doses

定义与Talquetamab逐步增加剂量相关的细胞因子释放综合征的发生率

BLOOD
IF23.1
2024-11-050
PRE
Hamadeh, Issam S.; Shekarkhand, Tala; Rueda, Colin; Firestone, Ross S.; Wang, Alice X.; Korde, Neha; Hultcrantz, Malin; Lesokhin, Alexander M.; Mailankody, Sham; Hassoun, Hani; Shah, Urvi A.; Maclachlan, Kylee H.; Rajeeve, Sridevi; Hashmi, Hamza; Shah, Gunjan L.; Scordo, Michael; Chung, David J.; Landau, HeatherJ.; Giralt, Sergio A.; Usmani, Saad Z.; Tan, Carlyn Rose
Body Mass Index Trajectory during Triplet Induction Therapy: Clinical Implications in Newly Diagnosed Multiple Myeloma

三联诱导治疗期间体质量指数变化轨迹：新诊断多发性骨髓瘤的临床意义

BLOOD
IF23.1
2024-11-050
PRE
Thirugnanasambandam, Ram Prakash; Firestone, Ross S.; Derkach, Andriy; Furberg, Helena; Shekarkhand, Tala; Rueda, Colin; Maclachlan, Kylee H.; Hultcrantz, Malin; Mailankody, Sham; Patel, Dhwani; Lahoud, Oscar Boutros; Landau, Heather J.; Chung, David J.; Shah, Gunjan L.; Scordo, Michael; Hassoun, Hani; Lesokhin, Alexander M.; Giralt, Sergio; Korde, Neha; Usmani, Saad Z.; Tan, Carlyn Rose; Shah, Urvi A.
Genomic Complexity Correlates with the Degree of Marrow Independence of Malignant Plasma Cells in the Context of Extramedullary Disease

基因组复杂性与人髓外疾病背景下恶性浆细胞的骨髓独立性程度相关。

BLOOD
IF23.1
2024-11-051
PRE
Maclachlan, Kylee H.; Garces, Juan-Jose; Shekarkhand, Tala; Rajeeve, Sridevi; Hashmi, Hamza; Hassoun, Hani; Hultcrantz, Malin; Korde, Neha; Tan, Carlyn Rose; Mailankody, Sham; Simhal, Anish; Chung, David J.; Shah, Gunjan L.; Scordo, Michael; Giralt, Sergio; Poos, Alexandra Maria; John, Lukas; Zhang, Yanming; Cimera, Robert; Arcila, Maria E.; Ossa, Juan E. Arango; Bhanot, Umesh; Jain, Mala; Merghoub, Tala; Landau, Heather J.; Lesokhin, Alexander M.; Usmani, Saad Z.; Weinhold, Niels; Maura, Francesco; Shah, Urvi A.
Frailty and Outcomes after Bispecific T-Cell Engager Therapy for Patients with Relapsed/Refractory Multiple Myeloma

老年虚弱及双特异性T细胞接合剂疗法在复发/难治性多发性骨髓瘤患者中的结局

BLOOD
IF23.1
2024-11-050
PRE
Adegbite, Benjamin O.; Tan, Carlyn Rose; Shekarkhand, Tala; Firestone, Ross S.; Jurgens, Eric M.; Miller, Kevin; Lesokhin, Alexander M.; Shah, Gunjan L.; Korde, Neha; Rajeeve, Sridevi; Chung, David J.; Landau, Heather J.; Scordo, Michael; Hassoun, Hani; Maclachlan, Kylee H.; Shah, Urvi A.; Hultcrantz, Malin; Hamadeh, Issam S.; Giralt, Sergio; Mailankody, Sham; Usmani, Saad Z.; Hashmi, Hamza
Real-World Safety and Early Efficacy of Talquetamab in Patients with Heavily-Pretreated Relapsed/Refractory Multiple Myeloma

真实世界安全性及早期疗效：Talquetamab在重度预治疗复发/难治性多发性骨髓瘤患者中的应用

BLOOD
IF23.1
2024-11-050
PRE
Costa, Bruno Almeida; Tan, Carlyn Rose; Shekarkhand, Tala; Firestone, Ross S.; Jurgens, Eric M.; Miller, Kevin; Lesokhin, Alexander M.; Shah, Gunjan L.; Korde, Neha; Rajeeve, Sridevi; Chung, David J.; Landau, Heather J.; Scordo, Michael; Hassoun, Hani; Maclachlan, Kylee H.; Shah, Urvi A.; Hultcrantz, Malin; Hamadeh, Issam S.; Giralt, Sergio; Mailankody, Sham; Usmani, Saad Z.; Hashmi, Hamza
Evaluating serum free light chain ratio as a biomarker in multiple myeloma
HAEMATOLOGICA
IF7.9
2024-10-030
OAAI
Akhlaghi, Theresia; Maclachlan, Kylee; Korde, Neha; Mailankody, Sham; Lesokhin, Alexander M.; Hassoun, Hani; Lu, Sydney X.; Patel, Dhwani; Shah, Urvi A.; Tan, Carlyn R.; Derkach, Andriy; Lahoud, Oscar B.; Landau, Heather J.; Shah, Gunjan L.; Scordo, Michael; Chung, David J.; Giralt, Sergio A.; Usmani, Saad Z.; Landgren, Ola; Hultcrantz, Malin
Colesevelam for lenalidomide associated diarrhea in patients with multiple myeloma
BLOOD CANCER JOURNAL
IF11.6
2024-09-190
OAAI
Hultcrantz, Malin; Hassoun, Hani; Korde, Neha; MacLachlan, Kylee; Mailankody, Sham; Patel, Dhwani; Shah, Urvi A.; Tan, Carlyn Rose; Chung, David J.; Lahoud, Oscar B.; Landau, Heather J.; Scordo, Michael; Shah, Gunjan L.; Giralt, Sergio A.; Pianko, Matthew J.; Burge, Miranda; Barnett, Kelly; Salcedo, Meghan; Caple, Julia; Tran, Linh; Blaslov, Jenna; Shekarkhand, Tala; Hamid, Selena; Nemirovsky, David; Derkach, Andriy; Arisa, Oluwatobi; Peer, Cody J.; Figg, William D.; Usmani, Saad Z.; Landgren, Ola; Lesokhin, Alexander M.
Unscheduled health care interactions in patients with multiple myeloma receiving T-cell redirection therapies
BLOOD ADVANCES
IF7.1
2024-06-140
OAAI
Howard, Anna J.; Concepcion, Isabel; Wang, Alice X.; Hamadeh, Issam S.; Hultcrantz, Malin; Mailankody, Sham; Tan, Carlyn; Korde, Neha; Lesokhin, Alexander M.; Hassoun, Hani; Shah, Urvi A.; Maclachlan, Kylee H.; Rajeeve, Sridevi; Landau, Heather J.; Scordo, Michael; Shah, Gunjan L.; Lahoud, Oscar B.; Chung, David J.; Giralt, Sergio; Usmani, Saad Z.; Firestone, Ross S.

研究方向

暂未获取到该数据
S
Sham Mailankody
H 指数:47论文数:455被引数:8,504
M
Malin Hultcrantz
H 指数:43论文数:439被引数:6,954
A
Alexander M. Lesokhin
H 指数:56论文数:560被引数:2.4万
U
Urvi A. Shah
H 指数:32论文数:379被引数:4,154
H
Hani Hassoun
H 指数:47论文数:415被引数:9,010
C
Carlyn Tan
H 指数:26论文数:257被引数:3,169
O
Ola Landgren
H 指数:102论文数:1,426被引数:4.3万
S
Saad Z. Usmani
H 指数:85论文数:1,145被引数:3.9万
G
Gunjan L. Shah
H 指数:43论文数:663被引数:8,077
K
Kylee Maclachlan
H 指数:19论文数:331被引数:1,744